Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 21, 2019
IQVIA™ has announced the launch of the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform. This innovative tool enables increases in clinical trial patient recruitment, engagement and retention by ensuring ...
read more
IQVIA and Genomics England announced a collaboration to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients.
read more
Wednesday, October 17, 2018
IQVIA announced the pharmaceuticals division of Roche has selected IQVIA’s commercial technology suite for deployment across more than 100 markets.
read more
IQVIA™ announced that Ferring Pharmaceuticals has selected IQVIA Technologies’ OCE platform for global deployment across more than 50 markets.
read more
Friday, November 30, 2018
IQVIA announced Napo has selected OCE, IQVIA’s commercial solutions suite, to support Napo’s commercial organization and enable it to work more closely with healthcare providers.
read more
Thursday, August 03, 2017
IriSys announced that it has been awarded a new "CRO Support for Drug Product Development, Manufacture, and Stability Studies" contract by the NCATS at the NIH.
read more
IRISYS, LLC, a San Diego-based contract pharmaceutical development and manufacturing services company, announced that it has been issued U.S. Patent No. 11,033,530, Liposomal Anticancer Compositions. IRISYS scientists discovered a new way to deliver ...
read more
Irvine Pharmaceutical Services, a leading provider of cGMP contract development and manufacturing services for the pharmaceutical, biotech, and medical device industries since 1988, is pleased to announce it successfully completed a five day cGMP ...
read more
Wednesday, January 02, 2019
FUJIFILM Irvine Scientific, a US subsidiary of FUJIFILM Corporation announced that on January 1, 2019 in the United States, the company changed its name from Irvine Scientific Sales Company, Inc.
read more
ISA announced plans to initiate a trial for the combination of ISA101b and Libtayo in oropharyngeal cancer.
read more
Isarna Therapeutics GmbH announced today that it
has signed a strategic manufacturing agreement with Sanofi under which Sanofi will
manufacture clinical- and commercial-grade antisense oligonucleotide (ASO) compounds for
Isarna, enabling Isarna to...
read more
In the pharmaceutical industry, the traceability of prescription drugs is increasingly vital to the integrity of these products.
read more
Isogenica announced a new licensing deal with Takeda, a global research and development-driven pharmaceutical company focused on oncology, gastroenterology and central nervous system disorders.
read more
Tuesday, November 24, 2020
Isohelix announced its GeneFiX Saliva RNA Collection Device is the technology of choice for COVID-19 testing by Precision Genetics.
read more
ISPE, the International Society for Pharmaceutical Engineering, announced today that it will work with stakeholders world-wide to produce a Drug Shortages Prevention Plan to guide the pharmaceutical and biopharmaceutical industry in establishing ...
read more